Binding of Neutralizing Monoclonal Antibodies to Empty Capsids of Poliovirus Can Be Blocked by Monospecific Antisera to Structural Polypeptides VP1 and VP2

Overview

Journal Arch Virol

Specialty Microbiology

Date 1985 Jan 1

PMID 2578787

Authors

H Uhlig

F Haardt

R Dernick

Affiliations

Soon will be listed here.

Abstract

Binding of two neutralizing monoclonal antibodies (Nt-mAbs) to natural empty capsids (NEC) of poliovirus, type 1, was blocked to the extent of 83 per cent to 98 per cent by monospecific rabbit antisera directed against the structural polypeptides VP1 and VP2. Monospecific antisera against VP3 or VP4, however, did not show this blocking effect. It is therefore assumed that VP1 and VP2 are located close together at the antigenic sites for the two mAbs.

References

Massey R, Schochetman G . Topographical analysis of viral epitopes using monoclonal antibodies: mechanism of virus neutralization. Virology. 1981; 115(1):20-32. DOI: 10.1016/0042-6822(81)90085-4. View

Icenogle J, Gilbert S, Grieves J, Anderegg J, Rueckert R . A neutralizing monoclonal antibody against poliovirus and its reaction with related antigens. Virology. 1981; 115(1):211-5. DOI: 10.1016/0042-6822(81)90103-3. View

Hammarstrom S, Engvall E, Johansson B, Svensson S, Sundblad G, Goldstein I . Nature of the tumor-associated determinant(s) of carcinoembryonic antigen. Proc Natl Acad Sci U S A. 1975; 72(4):1528-32. PMC: 432570. DOI: 10.1073/pnas.72.4.1528. View

Hummeler K, ANDERSON T, BROWN R . Identification of poliovirus particles of different antigenicity by specific agglutination as seen in the electron microscope. Virology. 1962; 16:84-90. DOI: 10.1016/0042-6822(62)90205-2. View

Wiegers K, Dernick R . Monospecific antisera against capsid polypeptides of poliovirus type 1 distinguish antigenic structures of poliovirus proteins. J Gen Virol. 1983; 64 (Pt 4):777-85. DOI: 10.1099/0022-1317-64-4-777. View

Rombaut B, Vrijsen R, Brioen P, Boeye A . A pH-dependent antigenic conversion of empty capsids of poliovirus studied with the aid of monoclonal antibodies to N and H antigen. Virology. 1982; 122(1):215-8. DOI: 10.1016/0042-6822(82)90393-2. View

Putnak J, Phillips B . Differences between poliovirus empty capsids formed in vivo and those formed in vitro: a role for the morphopoietic factor. J Virol. 1981; 40(1):173-83. PMC: 256607. DOI: 10.1128/JVI.40.1.173-183.1981. View

Stone M, Nowinski R . Topological mapping of murine leukemia virus proteins by competition-binding assays with monoclonal antibodies. Virology. 1980; 100(2):370-81. DOI: 10.1016/0042-6822(80)90528-0. View

Drzeniek R, Bilello P . Absence of glycoproteins in poliovirus particles. J Gen Virol. 1974; 25(1):125-32. DOI: 10.1099/0022-1317-25-1-125. View

10.

Meloen R, Rowlands D, Brown F . Comparison of the antibodies elicited by the individual structural polypeptides of foot-and mouth disease and polio viruses. J Gen Virol. 1979; 45(3):761-3. DOI: 10.1099/0022-1317-45-3-761. View

11.

Uhlig H, RUTTER G, Dernick R . Evidence for several unrelated neutralization epitopes of poliovirus, type 1, strain Mahoney, provided by neutralization tests and quantitative enzyme-linked immunosorbent assay (ELISA). J Gen Virol. 1983; 64 ( Pt 12):2809-12. DOI: 10.1099/0022-1317-64-12-2809. View

12.

Hawkes R, Niday E, Gordon J . A dot-immunobinding assay for monoclonal and other antibodies. Anal Biochem. 1982; 119(1):142-7. DOI: 10.1016/0003-2697(82)90677-7. View

13.

Wiegers K, Drzeniek R . Preparative isoelectric focusing of poliovirus polypeptides in urea-sucrose gradients. J Gen Virol. 1980; 47(2):423-30. DOI: 10.1099/0022-1317-47-2-423. View

14.

Dernick R, Heukeshoven J, Hilbrig M . Induction of neutralizing antibodies by all three structural poliovirus polypeptides. Virology. 1983; 130(1):243-6. DOI: 10.1016/0042-6822(83)90134-4. View

15.

Evans D, Minor P, Schild G, Almond J . Critical role of an eight-amino acid sequence of VP1 in neutralization of poliovirus type 3. Nature. 1983; 304(5925):459-62. DOI: 10.1038/304459a0. View

16.

Wiegers K, Drzeniek R . Isolation and characterization of 'dense particles' from poliovirus-infected HeLa cells. J Gen Virol. 1975; 26(3):307-19. DOI: 10.1099/0022-1317-26-3-307. View

17.

Taniguchi K, URASAWA S, Urasawa T . Monoclonal antibodies reactive with different sites of N and H antigenic particles of poliovirus. J Gen Virol. 1983; 64 ( Pt 12):2803-8. DOI: 10.1099/0022-1317-64-12-2803. View

18.

Putnak J, Phillips B . Poliovirus empty capsid morphogenesis: evidence for conformational differences between self- and extract-assembled empty capsids. J Virol. 1982; 41(3):792-800. PMC: 256816. DOI: 10.1128/JVI.41.3.792-800.1982. View

19.

Emini E, Jameson B, Lewis A, Larsen G, Wimmer E . Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies. J Virol. 1982; 43(3):997-1005. PMC: 256210. DOI: 10.1128/JVI.43.3.997-1005.1982. View

20.

Katze M, CROWELL R . Indirect enzyme-linked immunosorbent assay (ELISA) for the detection of Coxsackievirus group B antibodies. J Gen Virol. 1980; 48(1):225-9. DOI: 10.1099/0022-1317-48-1-225. View